MT-1 (10mg) Spray

MT-1 (Melanotan-1) 10 mg – Research Compound

MT1, or Afamelanotide, is a synthetic analogue of the naturally occurring peptide alpha-melanocyte-stimulating hormone (α-MSH). It is a non-selective agonist of the melanocortin receptors, primarily targeting MC1R on skin cells. Researchers study MT1 for its ability to stimulate melanogenesis (the production of melanin) independently of ultraviolet (UV) radiation. It is investigated as a photoprotective agent, with studies focusing on its ability to increase skin pigmentation and reduce DNA damage caused by solar exposure.

Findings from early-stage clinical trials have reported:

• Significant increases in skin melanin density and pigmentation observed in research subjects
  
• Reductions in the severity of skin damage and solar urticaria reported in experimental models
  
• Protective effects against UV-induced oxidative stress and DNA damage noted in-vitro
  
• Improved skin tolerance to light exposure reported across multiple clinical study groups
  

Researchers study MT1 to explore the mechanisms of biological photoprotection and the prevention of UV-linked dermal pathologies. By analyzing the activation of the MC1R pathway, it serves as a specialized tool for understanding the body’s innate defense against radiation. This makes it an essential compound for research into erythropoietic protoporphyria (EPP), skin cancer prevention, and the regulation of pigmentation markers.

Available Formats:
This compound is available in a 9ml premixed spray bottle, providing a stable solution for precise administration in research settings.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use